|
|
|
|
- A recent report shows focused ultrasound being safely used on a patient who had previously been implanted with DBS leads.
- The patient successfully underwent the procedure to treat their movement disorder.
|
|
|
|
|
|
|
|
|
|
|
|
- The data are from the US and European prospective, multi-center trials called #HOPE4LIVER.
- Since FDA clearance in 2023, HistoSonics’ Edison histotripsy system has been used to treat more than 1,000 patients with liver tumors.
|
|
|
|
|
|
|
|
|
|
|
|
- HistoSonics has commercialized the Edison histotripsy system, which is now being used at nearly 50 centers in the US, United Arab Emirates, and Hong Kong.
- Learn more about the company’s achievements, current direction, and future plans.
|
|
|
|
|
|
|
|
|
|
|
|
- Elissa chose histotripsy to treat liver tumors that had spread from colon cancer and hoped the therapy would give her more time with her daughter.
- This patient story from the Detroit Free Press is interwoven with the journey of histotripsy inventor, Zhen Xu, PhD, as she and her team worked to bring the technology to patients like Elissa.
|
|
|
|
|
|
|
|
|
|
|
|
- Anson M. Beard, Jr., played a pivotal role in expanding Morgan Stanley’s global equity division.
- He explains why he thinks focused ultrasound is a “win” for the future of health.
|
|
|
|
|
|
|
|
|
|
|
|
- Six recent conferences featured focused ultrasound presentations.
- See content from SIR, AIUM, ECIO, SOBP, AANS, and AACR.
|
|
|
|
|
|
|
|
|
|
|
|
- The award enables researchers to access the equipment and support that they require to carry out projects related to noninvasive brain stimulation or imaging techniques.
- Interested applicants should apply by June 1.
|
|
|
|
|
|
|
|
|
|
“The vision and potential of histotripsy has always been to benefit patients across an unparalleled number of broad clinical applications, both malignant and benign, and we are just at the very, very beginning of our journey.”
‒ Mike Blue, HistoSonics |
|
|
|
|
|
|